Ventfort

Substance: Vascular peptide bioregulator · Target tissue: Blood vessels — microcirculation

Vessel-wall bioregulator line; Russian vascular literature is the main record.

Extract counterpart: Related extract line: Vasalamin (vessel-wall bioregulator)

Matched publications in database: 7 (EXTRACT 1, SYNTHETIC 2, EXTRACT→SYN 0)

Extract vs synthetic gap: the human outcome data (including the 266-patient mortality cohort) was collected on extracts; vendors sell synthetic fragments. No head-to-head trial exists — evidence does not transfer between them. Details →

Khavinson studies (7 matched, 1991–2023)

Keyword-filtered from the 472-publication database (khavinson.info). EXTRACT/SYNTHETIC tags are title-text heuristics — verification is on the reader. Full tag legend: evidence-tiers.html

[1] [Khavinson V., Linkova N., Dyatlova A., Kantemirova R., Kozlov K. Senescence-Associated Secretory Phenotype of Cardiovascular System Cells and Inflammaging: Perspectives of Peptide Regulation. // Cells. – 2023. – Vol. 12, Iss. 1, 106. – 22 p.](https://khavinson.info/assets/files/skan/2023-khavinson_linkova_dyatlova.pdf) DOI: 10.3390/cells12010106 (2023)syn DOI:10.3390/cells12010106 [PDF]
[44] Sokolova I.B., Ryzhak G.A., Khavinsov V.Kh. Functional Cumulation of the Influence of Vascular Peptide Bioregulator on Microcirculation in the Brain Cortex of Spontaneously Hypertensive Rats. // Advances in Gerontology. – 2018. – Vol. 8, N 2. – P. 158-162. (2018)untag [PDF]
[58] Sokolova I.B., Sergeev I.V., Ryzhak G.A., Khavinson V.Kh. The Effect of Vascular Peptide Bioregulator on Microcirculation in the Brain Cortex of Old Rats. // Advances in Gerontology. – 2016. – Vol. 6, No 4. – P. 328-332. (2016)syn [PDF]
[63] Khavinson V.Kh., Tarnovskaya S.I., Linkova N.S., Gutop E.O., Elashkina E.V. Epigenetic Aspects of Peptidergic Regulation of Vascular Endothelial Cell Proliferation in Aging. // Advances in Gerontology. – 2015. – Vol. 5, No 4. – P. 219-224. (2015)untag [PDF]
[61] Sedova E., Alexeeva N., Kozlov K., Khavinson V. Choice of Tactics in Endovascular Treatment of Generalized Atherosclerosis by Elderly Patients. // The 20th IAGG World Congress of Gerontology and Geriatrics. - Seoul, Korea. - 2013. - The Journal of Nutrition, Health & Aging. - Vol. 17, Suppl. 1. - P. 771. (2013)untag
[213] Solovyova D.V., Khavinson V.Kh., Schwarts E.I. Molecular-genetic investigation and prevention of cardiovascular pathology development. // Abstr. of the International Conference on Biomedical Aspects of Aging Research. - Venice, Italy. - 1997. - C-7: P-58. (1997)untag
[230] Yakovlev G.M., Khavinson V.Kh., Pavlenko V.S., Andreeva L.I., Ershov V.I., Merkurjeva G.A. Heart peptides - a new antiischemic preparation. // 4th International Symposium on Cardiovascular Pharmacotherapy “Cardiovascular drugs and therapy”. - Abstr.: Cardiovascular drugs and therapy. - 1991. - Vol. 5, Suppl. 3. - P. 408. (1991)ext

Independent (non-Khavinson) studies

None catalogued. To date there are zero independent Western human trials of any Khavinson compound, in any year. Independent in-vitro data exists for Epitalon only (two 2025 studies). If a study belongs here, add it to non-khavinson-research.json and rebuild.

Reddit meta-scrape

No Reddit community discussion exists for this compound. This is honest reporting — the peptide has essentially zero anecdotal footprint in the biohacking community. Absence of anecdotes is not evidence of safety or efficacy, but it does mean there is no community-level signal to analyze.

Measurement protocol — concrete testable endpoints

Doppler flow, microcirculation assessment, BP monitoring.

All endpoints on one page: measurement-protocols.html · Evidence-tier legend: evidence-tiers.html

← Cardiogen Directory Epitalon (AEDG) →